Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting the ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...

The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.

Boehringer Ingelheim (BI) and Click Therapeutics have ... the existing collaboration in effect since September 2020. The CT-155 programme achieved all development milestones to-date and generated ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

To our knowledge, this is the first intestinal ultrasound appropriateness rating exercise conducted for defining, diagnosing, ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

CT sees $13.5M in revenue from ‘nips’ bottles in three years. See how much your town got this year. CT sees $13.5M in revenue from 'nips' bottles in three years. See how much your town got ...